State Street Corp acquired a new stake in Monogram Orthopaedics, Inc. (NASDAQ:MGRM – Free Report) during the third quarter, Holdings Channel.com reports. The firm acquired 23,300 shares of the company’s stock, valued at approximately $62,000.
Monogram Orthopaedics Stock Performance
Monogram Orthopaedics stock opened at $2.40 on Friday. Monogram Orthopaedics, Inc. has a 52 week low of $1.53 and a 52 week high of $4.90. The firm has a market capitalization of $82.35 million, a PE ratio of -5.11 and a beta of 1.51. The business’s 50-day simple moving average is $2.33 and its 200-day simple moving average is $2.45.
Analyst Ratings Changes
Several equities analysts have commented on the company. Roth Capital upgraded Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th. Roth Mkm started coverage on shares of Monogram Orthopaedics in a research note on Monday, December 9th. They issued a “buy” rating and a $4.00 target price on the stock.
Monogram Orthopaedics Company Profile
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Read More
- Five stocks we like better than Monogram Orthopaedics
- What is a Death Cross in Stocks?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- How to invest in marijuana stocks in 7 steps
- Nebius Group: The Rising Star in AI Infrastructure
- 3 Best Fintech Stocks for a Portfolio Boost
- MarketBeat Week in Review – 12/30 – 1/03
Want to see what other hedge funds are holding MGRM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monogram Orthopaedics, Inc. (NASDAQ:MGRM – Free Report).
Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.